[1]BOTTONI P,SCATENA R.The role of CA 125 as tumor marker:biochemical and clinical aspects[J].Adv Exp Med Biol,2015,867:229-244.
|
[2]HUANG XM,QIU JG,HONG RK,et al.Correlation analysis of serum CA125 level between Child-Pugh classification,CHE and volume of ascites in patients with cirrhosis[J].J Hepatopancreatobiliary Surg,2016,28(1):13-16.(in Chinese)黄喜岷,邱建国,洪睿珂,等.肝硬化患者血清CA125水平与Child-Pugh分级、CHE及腹水量相关性分析[J].肝胆胰外科杂志,2016,28(1):13-16.
|
[3]SCHUPPAN D,AFDHAL NH.Liver cirrhosis[J].Lancet,2008,371(9615):838-851.
|
[4]European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis[J].J Hepatol,2010,53(3):397-417.
|
[5]HUANG XD,WANG ZQ,XU Z,et al.Importance of detecting cancer antigen 125 in patients with liver cirrhosis with ascites[J].J Clin Hepatol,2003,19(3):143-144.(in Chinese)黄晓东,王子强,徐章,等.癌相关抗原125对慢性肝病合并腹水的诊断价值[J].临床肝胆病杂志,2003,19(3):143-144.
|
[6]QURESHI MO,DAR FS,KHOKHAR N.Cancer antigen-125 as a marker of ascites in patients with liver cirrhosis[J].J Coll Physicians Surg Pak,2014,24(232):5.
|
[7]CHOWDHURY MA,XIUBIN Z,WEI H,et al.Cancer antigen-125 and ICAM-1 are together responsible for ascites in liver cirrhosis[J].Clin Lab,2013,60(4):653-658.
|